HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates

Acta Cytologica

Volumn 50, Issue 3, 2006, Pages 257-262

  Wang, Luoquan ^a   Vuolo, Magalis ^a   Suhrland, Mark J ^a   Schlesinger, Kathie ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Hepatocellular carcinoma; Immunohistochemistry; Liver cancer

Indexed keywords

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HEPATOCYTE PARAFFIN 1 PROTEIN; MOC 31 PROTEIN; MONOCLONAL ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CELL CARCINOMA; METASTATIC ADENOCARCINOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 33744784568     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325951     Document Type: Article

References (40)

1. Siddiqui M, Saboorian M, Gokaslan S, Ashfaq R: Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine needle aspiration samples. Cancer Cytopathology 2001;30:49-52
2. Bedrossian CW, Davila RM, Merenda G: Immunocytochemical evaluation of liver fine-needle aspirations. Arch Pathol Lab Med 1989;113:1225-1230
3. Lin F, Meschter S: Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine needle aspiration biopsy (FNAB) of the liver. Diagn Cytopathol 2003;30:92-97
4. Ma CK, Zarbo RJ, Frierson HF Jr, Lee MW: Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Am J Clin Pathol 1993;99:551-557
5. Carrozza MJ, Calafati SA, Edmonds PR: Immunocytochemical localization of polyclonal carcinoembryonic antigen in hepatocellular carcinomas. Acta Cytol 1991;35:221-224
6. Christensen WN, Boitnott JK, Kuhajda FP: Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma. Mod Pathol 1989;2:8-12
7. Fischer HP, Altmannsberger M, Weber K, Osborn M: Keratin polypeptides in malignant epithelial liver tumors: Differential diagnostic and histogenetic aspects. Am J Pathol 1987;127: 530-537
8. Fucich LF, Cheles MK, Thung SN, Gerber MA, Marrogi AJ: Primary vs metastatic hepatic carcinoma: An immunohistochemical study of 34 cases. Arch Pathol Lab Med 1994;118: 927-930
9. Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M: The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol 1996;9:901-909
10. Van Eyken P, Sciot R, Paterson A, Callea F, Kew MC, Desmet VJ: Cytokeratin expression in hepatocellular carcinoma: An immunohistochemical study. Hum Pathol 1988;19:562-568
11. Borscheri N, Roessner A, Rocken C: Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas. Am J Surg Pathol 2001;25:1297-1303
12. Leong AS, Sormunen RT, Tsui WM, Liew CT: Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumors and metastatic carcinoma. Histopathology 1998;33: 318-324
13. Niemann TH, Hughes JH, De Young BR: MOC-31 aids in the differentiation of metastatic adenocarcinoma from hepatocellular carcinoma. Cancer 1999;87:295-298
14. Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ: Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. Am J Clin Pathol 2003;119:361-366
15. Porcell AI, De Young BR, Proca DM, Frankel WL: Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers. Mod Pathol 2000;13:773-778
16. Lau SK, Prakash S, Geller SA, Alsabeh R: Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol 2002;33:1175-1181
17. Morrison C, Marsh W Jr, Frankel WL: A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol 2002;15:1279-1287
18. Chu PG, Ishizawa S, Wu E, Weiss LM: Hepatocyte antigen as a marker of hepatocellular carcinoma: An immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol 2002;26:978-988
19. Fan Z, van de Rijn M, Montgomery K, Rouse RV: Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 Tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol 2003;16:137-144
20. Saad RS, Luckasevic TM, Noga CM, Johnson DR, Silverman JF, Liu YL: Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology. Diagn Cytopathol 2004;30:1-6
21. Shah KD, Tabibzadeh SS, Gerber MA: Comparison of cytokeratin expression in primary and metastatic carcinomas: Diagnostic application in surgical pathology. Am J Clin Pathol 1987;87:708-715
22. Krepler R, Denk H, Artlieb U, Fichtinger E, Davidovits A: Antibodies to intermediate filament proteins as molecular markers in clinical tumor pathology: Differentiation of carcinomas by their reaction with different cytokeratin antibodies. Pathol Res Pract 1982;175:212-226
23. Hurlimann J, Gardiol D: Immunohistochemistry in the differential diagnosis of liver carcinomas. Am J Surg Pathol 1991;15: 280-288
24. Bottles K, Cohen M, Holly E, Chiu S, Abele J, Cell J: A step-wise logistic regression analysis of hepatocellular carcinoma. Cancer 1988;62:558-563
25. Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY: Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers: Clinical and biological implications. Am J Pathol 1996;149:1167-1175
26. Hayashi Y, Takanashi Y, Ohsawa H, Ishii H, Nakatani Y: Hepatoid adenocarcinoma in the lung. Lung Cancer 2002;38:211-214
27. Kishimoto T, Nagai Y, Kato K, Ozaki D, Ishikura H: Hepatoid adenocarcinoma: A new clinicopathological entity and the hypotheses on carcinogenesis. Med Electron Microsc 2000;33:57-63
28. Foschini MP, Macchia S, Baccarini P, Milandri GL, Losi L, Spongano P, Panarelli M, Dal Monte PR, Eusebi V: Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma. Pathologica 1999;91:260-267
29. Tsutsumi Y, Onoda N, Misawa M, Kuroki M, Matsuoka Y: Immunohistochemical demonstration of nonspecific cross-reacting antigen in normal and neoplastic human tissues using a monoclonal antibody: Comparison with carcinoembryonic antigen localization. Acta Pathol Jpn 1990;40:85-97
30. Wee A, Nilsson B: pCEA canalicular immunostaining in fine needle aspiration biopsy diagnosis of hepatocellular carcinoma. Acta Cytol 1997;41:1147-1155
31. Rishi M, Kovatich A, Ehya H: Utility of polyclonal and monoclonal antibodies against carcinoembryonic antigen in hepatic fine-needle aspirates. Diagn Cytopathol 1994;11:358-61; discussion 361-362
32. Kim JC, Gong G, Roh SA, Park KC: Carcinoembryonic antigen gene and carcinoembryonic antigen expression in the liver metastasis of colorectal carcinoma. Mol Cells 1999;9:133-137
33. Chu PG, Aber DA: Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms: Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 2000;113:374-382
34. Guiot MC, Sawka R, Meakins JL, Jothy S: Immunohistologic diagnosis of multiple carcinomas: The role of monoclonal antibodies against carcinoembryonic antigen. Can J Surg 1989;32: 279-282
35. Sheahan K, O'Brien MJ, Burke B, Dervan PA, O'Keane JC, Gottlieb LS, Zamcheck N: Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies. Am J Clin Pathol 1990;94:157-164
36. Jantscheff P, Bottger V, Price M, Micheel B, Kaiser G, Zotter S, Kotzsch M, Grossmann H, Karsten U: Production and characterization of monoclonal antibodies against carcinoembryonic antigen (CEA). Biomed Biochim Acta 1991;50:1261-1267
37. Nitzan DW, Livni N, Marmary Y, Ben-Baruch N, Sela J, Catane R: The use of monoclonal anti-CEA antibody immunohistochemistry in detecting the origin of oral cavity metastasis. Int J Oral Maxillofac Surg 1990;19:162-164
38. Wennerberg A, Ma N, Coleman W: Hepatocyte paraffin 1: A monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol 1993;143:1050-1054
39. Sosolik R, McGaughy VR, De Young BR. Anti-MOC-31: A potential addition to the pulmonary adenocarcinoma versus mesothelioma immunohistochemistry panel. Mod Pathol 1997; 10:716-719
40. Morgan RL, De Young BR, McGaughy VR, Niemann TH: MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells. Cancer 1999;87:390-394